These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26448076)

  • 21. Microarray technology: an array of opportunities.
    Gershon D
    Nature; 2002 Apr; 416(6883):885-91. PubMed ID: 11976691
    [No Abstract]   [Full Text] [Related]  

  • 22. Rediscovering the sweet spot in drug discovery.
    Brown D; Superti-Furga G
    Drug Discov Today; 2003 Dec; 8(23):1067-77. PubMed ID: 14693466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biotech slumps in Q1.
    Lawrence S
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract]   [Full Text] [Related]  

  • 24. Gene therapy: cursed or inching towards credibility?
    Branca MA
    Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
    [No Abstract]   [Full Text] [Related]  

  • 25. Time to choose.
    Aldhous P
    Nature; 2003 Oct; 425(6959):655. PubMed ID: 14562071
    [No Abstract]   [Full Text] [Related]  

  • 26. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 27. BCG report rosy on genomics.
    Fletcher L
    Nat Biotechnol; 2001 Aug; 19(8):703. PubMed ID: 11491102
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioentrepreneurship around the world.
    Persidis A
    Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
    [No Abstract]   [Full Text] [Related]  

  • 30. Damned if they do, damned if they don't..
    Giles J
    Nature; 2003 Oct; 425(6959):656-7. PubMed ID: 14562072
    [No Abstract]   [Full Text] [Related]  

  • 31. Betting on biogenerics.
    Dove A
    Nat Biotechnol; 2001 Feb; 19(2):117-20. PubMed ID: 11175723
    [No Abstract]   [Full Text] [Related]  

  • 32. Academic-industrial partnerships in drug discovery in the age of genomics.
    Harris T; Papadopoulos S; Goldstein DB
    Trends Biotechnol; 2015 Jun; 33(6):320-2. PubMed ID: 25987446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics and the world's economy.
    Enríquez J
    Science; 1998 Aug; 281(5379):925-6. PubMed ID: 9722465
    [No Abstract]   [Full Text] [Related]  

  • 34. Global trends in plant transgenic science and technology (1973-2003).
    Vain P
    Trends Biotechnol; 2006 May; 24(5):206-11. PubMed ID: 16569453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotech round the world: focus on Chile.
    Biotechnol J; 2007 Jun; 2(6):667-8. PubMed ID: 17570697
    [No Abstract]   [Full Text] [Related]  

  • 36. Genomics joint venture 2.
    Davies MJ
    Trends Biotechnol; 2001 May; 19(5):163. PubMed ID: 11301124
    [No Abstract]   [Full Text] [Related]  

  • 37. Aurora throws light on Vertex's aspirations.
    Fletcher L
    Nat Biotechnol; 2001 Jun; 19(6):496. PubMed ID: 11385416
    [No Abstract]   [Full Text] [Related]  

  • 38. Charting the biologic frontier. Interview by Val J. Halamandaris.
    Venter C
    Caring; 2003 Apr; 22(4):32-40. PubMed ID: 12722564
    [No Abstract]   [Full Text] [Related]  

  • 39. Around the world in a month.
    Nat Biotechnol; 2015 Sep; 33(9):896. PubMed ID: 26348948
    [No Abstract]   [Full Text] [Related]  

  • 40. Biotech boom.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):480-3. PubMed ID: 16049469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.